Unscheduled Hospital Readmission After Crenel Lateral Interbody Fusion

Zhejiang University

Status: Completed

Conditions: Spine Degeneration

Treatments: Procedure: Crenel Lateral Interbody Fusion; Procedure: Crenel lateral interbody fusion plus second stage surgery

Study type: Observational

Funder types: Other

Identifiers

NCT06614296

2024-0165

Details and patient eligibility

About

The goal of this observational study is to learn about the readmission related to Crenel Lateral Interbody Fusion (CLIF). The main question it aims to answer is:

What are the risk factors for readmission after CLIF surgery?

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with spinal degeneration undergoing CLIF surgery

Exclusion criteria

• Under the age of 18

Trial design

100 participants in 2 patient groups

Unscheduled readimission

Description:

Unscheduled readimission after CLIF

Treatment:

Procedure: Crenel lateral interbody fusion plus second stage surgery

Scheduled readimission

Description:

Scheduled readimission after CLIF

Treatment:

Procedure: Crenel Lateral Interbody Fusion